Position in ARCT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$214,280
-$24,082 QoQ
Shares Held
31,887
+3.3% QoQ
Ownership
0.112%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 133 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 16%
Shared 0%
None 84%
Common Shares in ARCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. ARCT ranks #241 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in ARCT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $214,280 | 31,887 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $238,362 | 30,876 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $188,056 | 30,678 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $732,445 | 39,742 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $522,182 | 40,137 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $354,775 | 33,501 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $560,756 | 33,044 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $765,860 | 32,997 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $832,429 | 34,186 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,268,671 | 37,568 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,140,093 | 36,159 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $930,965 | 36,437 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,025,654 | 35,762 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $728,664 | 30,399 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $494,892 | 29,180 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $418,887 | 28,265 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $404,486 | 25,698 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $725,951 | 26,927 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,085,836 | 29,339 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,416,294 | 29,642 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $970,091 | 28,667 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $882,994 | 21,380 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,077,255 | 24,833 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $723,465 | 16,864 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $809,677 | 17,323 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||